ASCENDIS PHARMA BONE DISEASES A/S — Credit Rating and Financial Key Figures
CVR number: 32323596
Tuborg Boulevard 12, 2900 Hellerup
Income statement (kEUR)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | -38 797.10 | -57 981.88 | -66 598.34 | - 112.33 | -34.02 |
| Costs of management | - 116.23 | - 116.61 | - 116.48 | -0.03 | -74.46 |
| EBIT | -38 913.32 | -58 098.50 | -66 714.83 | - 112.36 | - 108.48 |
| Other financial income | 0.00 | 0.97 | 1.04 | ||
| Other financial expenses | -2 468.63 | -3 867.87 | -5 584.67 | -7.76 | -32.17 |
| Pre-tax profit | -41 381.96 | -61 966.36 | -72 299.49 | - 119.14 | - 139.61 |
| Income taxes | 82.12 | 141.10 | 101.95 | 0.19 | 0.52 |
| Net earnings | -41 299.83 | -61 825.26 | -72 197.54 | - 118.96 | - 139.09 |
Assets (kEUR)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Machinery and equipment | 72.08 | 44.17 | 16.28 | ||
| Tangible assets total | 72.08 | 44.17 | 16.28 | ||
| Participating interests | 10 881.83 | 14 065.14 | |||
| Investments total | 10 881.83 | 14 065.14 | |||
| Non-current loans receivable | 14 065.14 | 14.06 | 14.06 | ||
| Long term receivables total | 14 065.14 | 14.06 | 14.06 | ||
| Inventories total | |||||
| Current trade debtors | 61.26 | 100.01 | 100.40 | 0.05 | 0.60 |
| Current amounts owed by group member comp. | 0.59 | ||||
| Prepayments and accrued income | 783.16 | ||||
| Current other receivables | 3 166.72 | 4 127.02 | 4 313.45 | ||
| Short term receivables total | 4 011.14 | 4 227.04 | 4 413.85 | 0.05 | 1.19 |
| Cash and bank deposits | 3 174.85 | 2.45 | 46.12 | 25.49 | 0.18 |
| Cash and cash equivalents | 3 174.85 | 2.45 | 46.12 | 25.49 | 0.18 |
| Balance sheet total (assets) | 18 139.89 | 18 338.81 | 18 541.39 | 39.61 | 15.43 |
Equity and liabilities (kEUR)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 67.02 | 67.02 | 67.02 | 0.07 | 0.07 |
| Shares repurchased | -72 197.54 | ||||
| Other reserves | -50.27 | -50.27 | 72 147.28 | -0.05 | |
| Retained earnings | -73 863.88 | - 115 163.72 | - 176 988.98 | - 249.19 | - 368.14 |
| Profit of the financial year | -41 299.83 | -61 825.26 | -72 197.54 | - 118.96 | - 139.09 |
| Shareholders equity total | - 115 146.96 | - 176 972.22 | - 249 169.77 | - 368.13 | - 507.16 |
| Non-current loans from credit institutions | 145.30 | ||||
| Non-current owed to group member | 128 546.80 | 195 305.15 | 267 705.24 | 407.73 | 373.55 |
| Non-current liabilities total | 128 546.80 | 195 305.15 | 267 705.24 | 407.73 | 518.85 |
| Current loans from credit institutions | 3.25 | ||||
| Current trade creditors | 0.01 | 0.51 | |||
| Other non-interest bearing current liabilities | 4 740.05 | 5.88 | 5.92 | ||
| Current liabilities total | 4 740.05 | 5.88 | 5.92 | 0.01 | 3.75 |
| Balance sheet total (liabilities) | 18 139.89 | 18 338.81 | 18 541.39 | 39.61 | 15.43 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.